✦ LIBER ✦
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
✍ Scribed by Messinger, Y. H.; Gaynon, P. S.; Sposto, R.; van der Giessen, J.; Eckroth, E.; Malvar, J.; Bostrom, B. C.
- Book ID
- 111868898
- Publisher
- American Society of Hematology
- Year
- 2012
- Tongue
- English
- Weight
- 227 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0006-4971
No coin nor oath required. For personal study only.